Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,155,721 | 586,576 | 1,970,335 | 1,412,741 | 919,048 |
| Depreciation Amortization | 91,783 | 39,148 | 155,610 | 115,217 | 67,119 |
| Income taxes - deferred | 20,409 | 11,305 | -24,969 | 18,498 | -158 |
| Accounts receivable | -217,911 | -89,073 | -257,161 | -259,086 | -183,951 |
| Accounts payable and accrued liabilities | 43,691 | -20,999 | 312,568 | 341,462 | 314,499 |
| Other Working Capital | -140,017 | -79,021 | -128,130 | -119,481 | -69,349 |
| Other Operating Activity | 310,571 | 193,394 | 115,131 | 55,746 | -627 |
| Operating Cash Flow | $1,264,247 | $641,330 | $2,143,384 | $1,565,097 | $1,046,581 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 41,194 | -164,318 | -52,963 | -333,198 | -49,601 |
| PPE Investments | -184,945 | -164,071 | -115,005 | -73,345 | -41,947 |
| Net Acquisitions | -1,247,816 | N/A | -10,851 | -10,851 | -6,768 |
| Investing Cash Flow | $-1,391,567 | $-328,389 | $-178,819 | $-417,394 | $-98,316 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 400,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -305,463 | -36 | -4,326 | -3,749 | -193 |
| Common Stock Issued | 102,093 | 40,947 | 246,125 | 176,416 | 135,564 |
| Common Stock Repurchased | -468,244 | -230,065 | -1,969,582 | -1,216,068 | -965,989 |
| Other Financing Activity | -30,420 | 43,413 | 253,214 | 149,255 | 77,426 |
| Financing Cash Flow | $-302,034 | $-145,741 | $-1,474,569 | $-894,146 | $-753,192 |
| Exchange Rate Effect | 10,926 | 37,144 | 1,220 | -12,219 | -43,560 |
| Beginning Cash Position | 1,459,302 | 1,459,302 | 968,086 | 968,086 | 968,086 |
| End Cash Position | 1,040,874 | 1,663,646 | 1,459,302 | 1,209,424 | 1,119,599 |
| Net Cash Flow | $-418,428 | $204,344 | $491,216 | $241,338 | $151,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,264,247 | 641,330 | 2,143,384 | 1,565,097 | 1,046,581 |
| Capital Expenditure | -184,945 | -164,071 | -115,005 | -73,345 | -41,947 |
| Free Cash Flow | 1,079,302 | 477,259 | 2,028,379 | 1,491,752 | 1,004,634 |